Financial Performance of Jasper Therapeutics for the Year Ending December 31 2023
Jasper Therapeutics recorded a net loss of $16.6 million and $64.5 million for the three months and the year ended ...
Tag: JSPR
Jasper Therapeutics Presents Groundbreaking Preclinical Data on Briquilimabs Effectiveness in Preventing Allergic Reactions in Mice
Jasper Therapeutics has announced that they will be presenting groundbreaking preclinical data on the effectiveness of Briquilimab, an anti-CD117 antibody, ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
